About Chimeric BioScience Consulting (CBC)
CBC provides best in class scientific solutions and support for various stages of therapeutic development supporting our customers that aim to bring medicines to patients that need them.
CBC accomplishes this by working hard to understand our pharmaceutical customer's challenges and offering solutions to help our customers achieve these critical needs. Because of our partnerships with best in class biotech and bioinformatics companies and our network of life science professionals CBC can define unique solutions that best meet the scientific and business needs of our customers.
Tristan Gill CEO and Founder
Tristan Gill is currently the CEO and Founder of CBC. Prior to founding CBC Tristan has 25 years of experience in top labs and companies including Cold Spring Harbor Laboratory, California Institute of Technology, Paracel a subsidiary of Celera Genomics, Rossetta BioSoftware a subsidiary of Merck & Co., Ingenuity now part of Qiagen, Bejing Genomics Institute (BGI), and Clarivate Analytics formerly Thomson Reuters. Tristan's success is attributed to his 3 principles: Understand the science and business of discovering and developing drugs, understand the customers unique needs and challenges and problem solve as a trusted partner to come up with an optimal solution.